Healthcare - Biotechnology - NASDAQ - US
$ 1.54
-8.33 %
$ 103 M
Market Cap
-0.77
P/E
CASH FLOW STATEMENT
-52.7 M
OPERATING CASH FLOW
-9.7 M
INVESTING CASH FLOW
35.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Generation Bio Co.
| Net Income | -127 M |
| Depreciation & Amortization | 5.26 M |
| Capital Expenditures | -7.4 M |
| Stock-Based Compensation | 24.3 M |
| Change in Working Capital | 53.5 M |
| Others | 43.2 M |
| Free Cash Flow | -60.1 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (126.6) | (136.6) | (119.2) | (80.5) | (61.3) | (35.8) |
| Depreciation & Amortization | 5.3 | 5.1 | 4.5 | 3.4 | 1.9 | 0.3 |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 10 K | 0 |
| Stock Based Compensation | 24.3 | 24.5 | 17.9 | 8.4 | 4.2 | 3.5 |
| Other Operating Activities | (9.3) | 3.6 | 0.8 | 0.2 | (0.3) | (0.8) |
| Change in Working Capital | 53.5 | 1.0 | 4.2 | (1.7) | 15.2 | 4.7 |
| Cash From Operations | (52.7) | (102.4) | (91.8) | (70.1) | (40.3) | (28.1) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (7.4) | (8.8) | (6.0) | (5.5) | (20.0) | (3.0) |
| Other Items | (2.3) | (183.7) | 199.0 | (199.7) | 68.0 | (66.7) |
| Cash From Investing Activities | (9.7) | (192.5) | 193.0 | (205.2) | 48.0 | (69.8) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.2) | 0.6 | 2.8 | 109.2 | 78 K | 100.2 |
| Cash From Financing Activities | 35.8 | 13.0 | 214.7 | 323.1 | 78 K | 100.2 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (26.6) | (282.0) | 315.9 | 47.8 | 7.7 | 2.3 |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (60.1) | (111.2) | (97.8) | (75.7) | (60.3) | (31.1) |